As of 2026-03-20, the Relative Valuation of Innocan Pharma Corp (INNO.CN) is 1.35 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 6.24 CAD, the upside of Innocan Pharma Corp based on Relative Valuation is -78.4%.
The range of the Relative Valuation is (0.08) - 3.48 CAD.
| Range | Selected | |
| Trailing P/E multiples | 0.1x - 2.0x | 0.1x |
| Forward P/E multiples | 7.7x - 12.0x | 9.6x |
| Fair Price | (0.08) - 3.48 | 1.35 |
| Upside | -101.3% - -44.2% | -78.4% |
| Date | P/E |
| 2026-03-10 | -6.67 |
| 2026-03-09 | -6.59 |
| 2026-03-06 | -5.98 |
| 2026-03-03 | -6.18 |
| 2026-03-02 | -6.84 |
| 2026-02-27 | -7.02 |
| 2026-02-26 | -6.94 |
| 2026-02-25 | -7.09 |
| 2026-02-24 | -7.42 |
| 2026-02-23 | -7.87 |
| 2026-02-20 | -8.45 |
| 2026-02-19 | -8.11 |
| 2026-02-18 | -8.19 |
| 2026-02-17 | -8.29 |
| 2026-02-12 | -7.72 |
| 2026-02-11 | -6.45 |
| 2026-02-10 | -7.30 |
| 2026-02-06 | -6.41 |
| 2026-02-05 | -7.33 |
| 2026-02-04 | -7.23 |
| 2026-02-03 | -8.57 |
| 2026-02-02 | -9.12 |
| 2026-01-30 | -9.60 |
| 2026-01-29 | -10.08 |
| 2026-01-28 | -7.45 |
| 2026-01-27 | -6.45 |
| 2026-01-26 | -6.09 |
| 2026-01-22 | -7.09 |
| 2026-01-21 | -7.74 |
| 2026-01-20 | -7.81 |
| 2026-01-16 | -8.11 |
| 2026-01-13 | -8.21 |
| 2026-01-12 | -8.68 |
| 2026-01-09 | -8.11 |
| 2026-01-08 | -8.12 |
| 2026-01-07 | -8.07 |
| 2026-01-06 | -8.21 |
| 2026-01-05 | -8.24 |
| 2026-01-02 | -7.63 |
| 2025-12-30 | -6.79 |
| 2025-12-29 | -6.89 |
| 2025-12-17 | -7.60 |
| 2025-12-16 | -7.60 |
| 2025-12-15 | -7.09 |